Weight loss medications like Mounjaro and Wegovy have become popular tools for managing weight. These GLP-1 receptor agonists help reduce appetite and improve blood sugar control, supporting effective weight management. Yet, one challenge many face during weight loss is muscle loss, which can affect strength, metabolism, and overall health. Understanding how protein and a balanced diet play a role in preserving muscle mass during weight loss is essential for anyone using thes

Researchers say daily calorie intake may be up to 10 times more influential than physical activity in weight gain.

Most people notice reduced appetite and better blood sugar levels within the first few weeks of starting Mounjaro. Visible weight loss tends to appear more gradually, often becoming noticeable after two to three months of consistent use. Long-term results are typically seen over several months as the medication supports steady, manageable progress. What happens in the first few weeks NICE and NHS guidance describe Mounjaro’s early effects as a period of “metabolic adjustment.

For kidney or liver issues, the dose ladder is usually the same, but clinicians monitor more closely. No routine dose adjustment is needed for mild-to-moderate impairment, yet dehydration from nausea or vomiting can stress the kidneys, so hydration and slower titration matter. In severe impairment or if labs are changing, prescribers may pause or hold at a lower step and review more frequently. Always flag any new swelling, dramatic fatigue, very dark urine, or reduced urine

Alcohol doesn’t change the prescribed dose, but it can aggravate stomach symptoms and undermine appetite cues, especially during dose...

Use once weekly, same day each week, with or without food, alongside a reduced-calorie eating plan and regular activity. Keep hydrated,...

Standard UK instructions start at 0.25 mg once weekly and step up gradually to improve comfort and reduce tummy side effects. Starting at 0.5 mg is not the routine plan and tends to increase nausea for first-time GLP-1 users. If you’ve previously tolerated a GLP-1, your prescriber will still weigh the pros and cons before deviating from the usual start. Why titration matters Wegovy contains semaglutide, a GLP-1 receptor agonist that acts on appetite control centres in the bra

Wegovy mimics the hormone GLP-1, acting on the brain to reduce appetite and slow digestion. Contrave (naltrexone/bupropion) affects brain reward and craving pathways, which can reduce emotional eating but doesn’t directly target satiety hormones. How Wegovy works Wegovy (semaglutide 2.4 mg weekly) is a GLP-1 receptor agonist. It mimics a natural gut hormone called GLP-1, which signals to the brain that you are full, slows down stomach emptying, and enhances insulin release wh

Neither Wegovy nor Saxenda requires strict dietary rules. Both are prescribed alongside a reduced-calorie diet and increased physical...

After stopping, many people regain some weight over time because appetite signals gradually return toward baseline. How much and how quickly varies, but the pattern is common across all weight-management approaches. Planning ahead helps: keep protein intake consistent, maintain activity that preserves strength, and agree a follow-up plan with your team (for example, a slower taper, maintenance strategies, or alternative support). If you stop because goals have been met, expec

There are no strict dietary restrictions, but simple tweaks help you feel better on treatment. Smaller portions, slower eating, and higher-protein meals reduce nausea and keep you fuller for longer. Early on, many people do better with lighter foods and by limiting very rich, spicy, or greasy dishes. Hydration matters — sip water regularly, and consider a little extra salt if you’ve cut back on processed foods and feel light-headed. Alcohol is best kept moderate, especially w

Energy levels often feel steadier as erratic snacking and large swings in intake settle down. Some people notice early fatigue during dose increases; this usually improves with better hydration, regular meals, and enough protein. If tiredness persists, your team can adjust the titration pace or check for other contributors such as low iron or not eating enough. What to expect in the first weeks Many people describe two parallel experiences at the start. On the one hand, appet

Wegovy was developed by Novo Nordisk as a higher-dose formulation of the GLP-1 receptor agonist semaglutide for chronic weight management, building on earlier experience with semaglutide for type 2 diabetes. Its evidence base comes from large, international STEP trials focused on weight and related health markers, with additional research exploring cardiovascular and kidney outcomes in selected groups. UK adoption is guided by national appraisals and commissioning policies; S

Wegovy does not “boost metabolism” in the thermogenic sense; its primary action is appetite regulation and reduced intake. As weight decreases, resting energy expenditure typically falls a little — that’s a normal adaptation seen with any weight loss. The meaningful advantage here is reduced hunger and cravings, which makes long-term behaviour change more realistic. Improvements in metabolic risk markers are observed in many users, but they stem from weight reduction and bett

The medicine is intended to sit alongside a reduced-calorie diet and regular movement, not replace them. People usually find it easier to meet protein targets, shrink portions, and cut between-meal snacking when appetite is quieter. Light-to-moderate activity protects muscle while weight comes down, and small daily habits (steps, resistance bands at home, shorter eating windows that suit you) compound gains without feeling punitive. UK services will tailor this mix and adjust

The first few weeks focus on getting used to weekly injections and allowing your body to adapt at a low dose. Common early effects...

Appetite suppression with semaglutide comes from activating GLP-1 receptors in brain regions that govern hunger and satisfaction,...

The weight loss market in the UK has always been dynamic—shifting with fads, social movements, and evolving ideas of health. From carb-cutting crazes to fitness influencers selling detox teas, consumer behaviour has long been influenced by whatever was trending. But lately, something different has been happening. Instead of chasing the next quick fix, more and more people are turning toward medically backed treatments—and much of that shift can be traced to the arrival of Weg

Wegovy didn’t just show up quietly in the world of weight management. It’s changed how clinics operate, how professionals approach...

Starting something new often feels exciting — a spark, a plan, a sense of momentum. But keeping that energy going? That’s where the real...